Microba Life Sciences Ltd Asset Resilience Ratio

Latest as of December 2025: 11.53%

Microba Life Sciences Ltd asset resilience ratio. Microba Life Sciences Ltd (MAP) has an Asset Resilience Ratio of 11.53% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Microba Life Sciences Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

AU$5.00 Million

≈ $3.54 Million USD Cash + Short-term Investments

Total Assets

AU$43.35 Million

≈ $30.68 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio of Microba Life Sciences Ltd (2018–2024)

Asset resilience ratio of Microba Life Sciences Ltd from 2018 to 2024. This chart shows how Microba Life Sciences Ltd's Asset Resilience Ratio has changed over time. See Microba Life Sciences Ltd (MAP) flexibility index to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Microba Life Sciences Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Microba Life Sciences Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$5.00 Million	11.53%
Short-term Investments	AU$0.00	0%
Total Liquid Assets	AU$5.00 Million	11.53%

Asset Resilience Insights

Moderate Liquidity: Microba Life Sciences Ltd has 11.53% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Microba Life Sciences Ltd Industry Peers by Asset Resilience Ratio

Compare Microba Life Sciences Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Revvity Inc. NYSE:RVTY	Diagnostics & Research	0.00%
Sonic Healthcare Ltd AU:SHL	Diagnostics & Research	0.13%
Voxel S.A. WAR:VOX	Diagnostics & Research	0.32%
Healius Ltd AU:HLS	Diagnostics & Research	0.06%
Monash Ivf Group Ltd AU:MVF	Diagnostics & Research	1.60%
Scope Fluidics SA WAR:SCP	Diagnostics & Research	16.51%
BioPorto CO:BIOPOR	Diagnostics & Research	55.77%
Cytogen Inc KQ:217330	Diagnostics & Research	32.97%

Microba Life Sciences Ltd Asset Resilience Ratio by Year (2018–2024)

Microba Life Sciences Ltd asset resilience ratio by year from 2018 to 2024. The table below shows the annual Asset Resilience Ratio data for Microba Life Sciences Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	6.02%	AU$2.85 Million ≈ $2.02 Million	AU$47.44 Million ≈ $33.56 Million	-1.60pp
2023-12-31	7.61%	AU$4.42 Million ≈ $3.13 Million	AU$58.04 Million ≈ $41.07 Million	-19.28pp
2022-12-31	26.90%	AU$12.63 Million ≈ $8.94 Million	AU$46.95 Million ≈ $33.22 Million	+25.86pp
2021-12-31	1.04%	AU$408.88K ≈ $289.31K	AU$39.48 Million ≈ $27.93 Million	+0.49pp
2020-12-31	0.54%	AU$100.60K ≈ $71.18K	AU$18.49 Million ≈ $13.08 Million	+0.08pp
2019-12-31	0.46%	AU$49.77K ≈ $35.22K	AU$10.81 Million ≈ $7.65 Million	--
2018-12-31	0.00%	AU$0.00 ≈ $0.00	AU$13.99 Million ≈ $9.90 Million	--

pp = percentage points

About Microba Life Sciences Ltd

AU:MAP Australia Diagnostics & Research

Market Cap

$15.08 Million

AU$21.31 Million AUD

Market Cap Rank

#25866 Global

#1123 in Australia

Share Price

AU$0.04

Change (1 day)

+0.00%

52-Week Range

AU$0.04 - AU$0.10

All Time High

AU$0.44